Adverse reactions to foods, such as allergies, sensitivities, and intolerances, are common issues in our society today, and appear to be rising at a significant rate. It is estimated that approximately 26 million adults and 5 million children in the US suffer from food allergies, with roughly 24% of Americans experiencing food intolerances. Food intolerances typically stem from the body's inability to properly digest certain foods, and are commonly associated with symptoms such as bloating, cramping, diarrhea, and nausea. In contrast, food allergies trigger a rapid IgE-mediated immune response that can cause life-threatening anaphylaxis. Food sensitivities fall between these two categories, involving slower, non-life-threatening immune activity that can cause a wide range of symptoms, including fatigue, joint pain, and neurological effects.
The standard approach to managing adverse food reactions is avoidance of trigger foods. However, emerging research suggests that food allergies and intolerances may be influenced by impaired intestinal barrier integrity and reduced short-chain fatty acid (SCFA) production, and may be improved by restoring a healthier gut environment. Butyrate is a key SCFA in the gastrointestinal tract that supports intestinal barrier integrity by regulating tight junction proteins and epithelial permeability, while also serving as the primary fuel source for colonic epithelial cells (colonocytes).
A recent case report examined the use of a butyrate-producing probiotic in a woman with long-standing food sensitivities and intolerances. The participant was a 47-year-old female with a history of gastritis, esophageal polyps, and general irritable bowel issues, including intolerance to gluten and dairy. Since her early 20s, she had experienced persistent heartburn, bloating, and digestive discomfort, and was eventually placed on a proton pump inhibitor (PPI). In the years leading up to the intervention, she tried multiple dietary strategies, including dairy-free, gluten-free, low FODMAP, and elimination diets, as well as various supplements and digestive enzymes, with little to no lasting improvement.
At the start of the 12-week protocol, the participant underwent baseline qPCR stool testing while symptoms were elevated. Results showed low levels of several obligate anaerobic taxa associated with butyrate production, including Akkermansia muciniphila, Faecalibacterium prausnitzii, and Roseburia spp., alongside elevated levels of opportunistic gram-negative organisms such as Morganella spp. and Prevotella spp. Based on these findings, she began supplementation with Anaerostipes caccae CLB101™, a butyrate-producing probiotic, at one capsule per day for eight weeks, followed by two capsules per day for an additional four weeks.
Following 12 weeks of supplementation, a second stool test was performed to assess changes in microbiota composition. The results demonstrated clear restoration of key anaerobic taxa alongside normalization of previously elevated opportunistic bacteria. Improvements observed on follow-up testing included:
Anaerobic taxa:
Opportunistic bacteria
Immune marker
During the twelve-week supplementation period, the patient reported progressive improvement in gastrointestinal complaints, including reductions in bloating and improved digestive comfort. By the end of the intervention, she was able to reintroduce previously reactive foods, particularly dairy, without gastrointestinal or systemic complaints. No adverse effects were noted during or after the intervention period, and the patient described a meaningful improvement in quality of life and dietary flexibility.
The findings from this case suggest that restoring microbial balance and function may play an important role in individuals with long-standing food intolerances. The increase in key anaerobic, butyrate-producing taxa alongside normalization of previously elevated opportunistic organisms reflects a meaningful shift in the gut environment. Following supplementation with Anaerostipes caccae, these findings support the potential role of restoring anaerobic, butyrate-producing taxa and normalizing opportunistic organisms in improving gut function and food tolerance.
While dietary avoidance remains the standard approach for managing food intolerances, this case highlights an alternative strategy focused on restoring the underlying gut environment. By supporting butyrate production through organisms such as Anaerostipes caccae, it may be possible to improve gut barrier function, reduce sensitivity to dietary triggers, and shift the microbiome away from a more dysbiotic state. As with any single case report, these findings reflect an individual response and may not be generalizable. Further research is needed to better understand how microbiome-targeted interventions, particularly those aimed at supporting butyrate production, may apply across broader populations with food intolerances, sensitivities, or allergies.
Learn more about butyrate, Anaerostipes caccae, and gut health:
Parallels in Butyrate Delivery: Comparative Insights into Tri-Butyrin and Anaerostipes
Two Next-Generation Probiotics You Should Know About: Anaerostipes and Akkermansia
Fueling the Gut: How Anaerostipes Caccae Powers Butyrate Production
The 5R Blueprint for Gut Health
By Jesse Martin, MS
Designs for Health has been dedicated to being the most trusted source for superior quality, science-based nutritional products for nearly three decades. We’re committed to maximizing successful health outcomes by providing healthcare practitioners with comprehensive support through our extensive product line, ongoing clinical education, and practice development programs. The blogs we publish here cover a range of topics, including new and original approaches to diet and healthcare, analyses of the latest cutting-edge research, deep-dives into specific nutrients, botanicals, nutraceuticals and more, all fully referenced for those who want to dig deeper into the primary literature.
